Main menu

NEW YORK (GenomeWeb News) – Luminex's third-quarter revenues rose 35 percent year over year with assay sales climbing 70 percent, the company reported after the close of the market on Tuesday.

The company said that total revenues in the quarter came in at $45.6 million for the three months ended Sept. 30, compared to $33.9 million a year ago, outpacing Wall Street estimates of $43.3 million.